INTRODUCTION
Nonarteritic anterior ischemic optic neuropathy (NAION) and central retinal artery occlusion (CRAO) usually manifest as a sudden, painless loss of vision. 1, 2 Even though the characteristics of NAION are often significantly different than those of CRAO, both conditions may cause a similar optic atrophy. Trobe et al reviewed 163 fundus stereo photographs of nine disease entities causing optic atrophy including NAION and CRAO and found that clinical assessment did not permit identifying the correct etiology in approximately 20% of cases. 3 Hayreh et al commented as well on the difficulty in diagnosing CRAO in its late stages due to the high incidence of normalappearing posterior pole, retinal vessels, and/or optic disc. 4 Distinguishing between CRAO and NAION is of clinical importance as reflected in the systemic workup advised. Patients with CRAO should be evaluated for an embolic source, whereas patients with NAION should be evaluated for an underlying vascular disease. 5, 6 Spectral-domain optical coherence tomography (SD-OCT) is a noncontact, noninvasive technique for high-resolution, cross-sectional imaging of various ocular structures that has been shown to be useful for evaluating a variety of retinal and optic nerve disorders including CRAO and NAION. [7] [8] [9] [10] [11] [12] However, no previous studies have used this tool for establishing distinguishing features between these conditions during the late phases, when optic atrophy is evident.
2008 and December 2011 with a diagnosis of CRAO or NAION. Patient-identifying data were retrieved from the files, and patients meeting the inclusion criteria were asked to participate in the study, which was approved by our institutional Declaration of Helsinki committee.
Inclusion criteria were: (1) a welldocumented history of acute NAION or CRAO in one eye only at least 3 months prior to study enrollment, (2) at least 6 months since any cataract surgery, and (3) no other retinal or optic nerve disease such as diabetic retinopathy, age-related macular degeneration, glaucoma, or any other disc abnormality that could affect visual function or OCT results.
All patients underwent a complete ophthalmological evaluation by a neuroophthalmologist, retina specialist, or both during the acute and resolving phases of the disease. The evaluation included an assessment of best corrected visual acuity (BCVA), pupillary response, and color vision. Slit lamp biomicroscopy, tonometry, and dilated funduscopy were performed as well. BCVA was measured using a Snellen chart. Results were converted to the logarithm of the minimum angle of resolution (logMAR) for statistical purposes. All patients with BCVA of 20/100 or better underwent visual field testing on the Humphrey Visual Field Analyzer (Carl Zeiss Meditec, Dublin, CA) using the Central 30-2 program. Goldmann perimetry or confrontation techniques were used for visual field assessment in patients in whom automated perimetry could not be performed.
All patients were previously seen during the acute phases of NAION when optic disc edema with or without peripapillary hemorrhages were observed and of CRAO when retinal edema or whitening, narrowing of retinal arteries, a cherry-red spot in the macula, arterial filling defects on fluorescein angiography, or a combination of these findings were present. All cases of CRAO were complete with no signs of perfusion of a cilioretinal artery. None of the patients demonstrated the typical symptoms suggestive of giant cell arteritis. Erythrocyte sedimentation rate and C-reactive protein (CRP) levels were determined in all patients. In two patients, a temporal artery biopsy was performed, the first in a 78-year-old woman with a slightly elevated sedimentation rate of 50 mm/hour and the second in a 64-year-old man with a CRP of 10.0 mg/L. Neither biopsy specimen showed histological evidence of arteritis.
SD-OCT scans of the macula and optic nerve were performed in all patients by an experienced examiner using the Heidelberg Spectralis SD-OCT (Heidelberg Engineering, Heidelberg, Germany). This instrument has a wavelength of 820 nm and provides 40,000 Ascans per second and an axial resolution of 7 mm. To ensure high quality and noise reduction, an eye tracking system and averaging technique were used. The macula was first scanned by a horizontal high-speed fast raster scanning protocol of a 20° × 20° quadrangular area, and then single 6-mm high speed scans were performed along horizontal and vertical planes through the center of the fovea; those scans consisted of 100 averaged high-speed OCT frames. Centration of the macula was verified by direct observation on the infrared and OCT screen. The fovea was identified as the patient's fixation point, if present, and on the OCT image by the foveal pit and/or the unique foveal architecture. The retinal thickness measurement was taken from the 1.3.6 ET-DRS macular thickness map centered at the fovea. The retinal thickness is defined on the SD-OCT instrument as the distance from the internal limiting membrane to the Bruch's membrane. The automated Heidelberg software segmentation of every single image of the cube composing the map was checked for errors and was corrected manually when needed. Attention was given to the central, mid, and peripheral macular thickness of each quadrant.
The peripapillary retinal nerve fiber layer (RNFL) thickness was measured by the standard glaucoma RNFL protocol at 256 points around a circle of 3.4 mm in diameter, centered on the optic disc. Data were processed with the software provided by the manufacturer (RNFL Thickness Single Exam Report). All RNFL automated Heidelberg software segmentations were checked for errors and were corrected manually. For each eye, the RNFL thickness was measured for all four quadrants: superior (315°-45°), nasal (45°-135°), inferior (135°-225°), and temporal (225°-315°). In addition, the global average RNFL thickness was determined for the entire 360°.
Statistical analysis was performed using SAS for windows software version 9.2. Retinal and RNFL thickness values were expressed as the mean ± standard deviation of the mean. The alpha level for statistical significance was set at 0.05. Background parameters were analyzed with the Fisher's exact test. LogMAR visual acuity in involved and uninvolved eyes, age, and the time interval from the event to study enrollment were analyzed with the nonparametric MannWhitney test. One-way analysis of variance (ANOVA) with repeat measurements and the interactions among them were used to compare the OCT measurements in eyes with CRAO or NAION and uninvolved eyes.
RESULTS
Twenty-four eyes with optic atrophy were included in this study, 12 secondary to NAION and 12 secondary to CRAO. In all patients, only one eye was involved, and the 24 uninvolved eyes served as controls. The demographic and clinical characteristics of all patients are summarized in Table 1 (page 39). Mean age of all patients was 65 years (range: 49-92 years), and the difference between patients with CRAO and NAION was not statistically significant (67.3 ± 11.7 years vs 63.2 ± 8.8 years; P = .345). At study entry, all patients had evidence of optic atrophy without any signs of optic disc or retinal edema. The mean duration from the acute event to enrollment was significantly longer in patients with CRAO compared with patients with NAION (35.5 ± 18.8 months vs 18.0 ± 8.0 months; P = .017).
BCVA ranged from 20/20 to hand motion in eyes with NAION and from 20/400 to no light perception in eyes with CRAO. Mean logMAR visual acuity in eyes with CRAO was significantly lower than in eyes with NAION (2.04 ± 0.66 vs 0.79 ± 0.74; P <.001). However, no significant difference was found in mean logMAR visual acuity in the uninvolved eyes of both groups (P = .526).
SD-OCT macular scans in eyes with CRAO revealed complete atrophy of all neurosensory layers with significant thinning of the retina, loss of the typical stratification of the inner retinal layers, and loss of the normal foveal pit, whereas eyes with NAION demonstrated thinning of the RNFL and ganglion cell layers with preservation of the normal retinal stratification ( Figure 1, page 39) .
All OCT macular and peripapillary RNFL thickness measurements were significantly lower in eyes with NAION and CRAO compared to control eyes ( Table 2, Figures 2 and 3 ). For instance, mean central macular thickness in eyes with CRAO and NAION were significantly lower than in control eyes (212.2 ± 30.5 µm and 257.3 ± 17.3 µm vs 274.5 ± 15.5 µm; P < .001). Mean global RNFL thickness in eyes with CRAO and eyes with NAION were also significantly lower than in control eyes (43.1 ± 9.0 µm and 53.4 ± 13.9 µm vs 93.5 ± 11.4 µm; P < .001). Analysis of the difference in each pair of eyes between the involved eye and the uninvolved eye revealed that the relative mean macular thinning following long-standing CRAO was significantly greater than following NAION (-59.7 ± 31.8 µm vs -19.9 ± 8.4 µm; P < .001). However, the mean peripapillary RNFL loss following CRAO was not statistically different than following NAION (-42.4 ± 18.5 µm vs -44.1 ± 12.4 µm; P = .726) (Figure 4 ). Funduscopic and macular and optic nerve images including thickness maps of a representative patient with CRAO and NAION are presented in Figures 5 and 6 , respectively.
DISCUSSION
This study has shown that long-standing CRAO and NAION have different qualitative and quantitative macular OCT features, even though both conditions result in a comparable degree of peripapillary RNFL loss.
OCT has been shown to be a useful tool for diagnosis and treatment of various retinal and optic nerve pathologies. 9 Its use following CRAO and NAION has been previously described in a small number of case series using different OCT instruments; however, none of the previous studies have performed a direct comparison between these conditions. In the current study, we have noted thinning of the macula and peripapillary RNFL in eyes with long-standing CRAO compared to uninvolved eyes. Similar findings were reported by Ikeda et al and Shinoda et al. 8, 12 Falkenberry et al reported a decrease in inner retinal layer reflectivity 3 months after CRAO and a corresponding increase in reflectivity in both the outer retina and the retinal pigment epithelium/choriocapillaris layer compared with baseline time-domain OCT taken at the time of the acute event; the authors suggest that a generalized atrophy of the neurosensory retina is a late finding after CRAO. 13 In our study, by using SD-OCT we were able to better demonstrate the morphological changes following CRAO, which include significant thinning of the neurosensory retinal layers and loss of normal retinal architecture. Macular time-domain OCT in NAION patients was performed by Papchenko et al, who found a significant thinning of the macula in involved eyes compared to fellow uninvolved eyes. 11 In their study, the mean central macular thickness in the involved eyes was on average 20 µm thinner than in the uninvolved eye. We found a similar result, with a mean central macular thinning of 19.9 µm in eyes with NAION compared to control eyes.
The difference in OCT macular features in NAION and CRAO can be explained by the retinal and optic nerve anatomy and blood supply. The retinal arterial system nourishes the inner retinal layers including the ganglion cell and the inner nuclear and inner and outer plexiform layers.
14 Histological changes following clamping of the central retinal artery in primates have shown necrosis of the inner retina, including the inner two-thirds of the inner nuclear layer, that was directly related to the duration of the arterial occlusion. 15 On the other hand, the outer one-third of the inner nuclear layer and photoreceptors including the fovea that are supplied by the choroidal vasculature were spared. In our study, we have shown in eyes with CRAO that these histological features were accurately mirrored in the SD-OCT images, which typically demonstrate marked retinal thinning and loss of the normal morphology and stratification of the inner retinal layers. Due to the significant thinning of the retina surrounding the foveal center, a loss of the normal foveal pit was seen. The pathogenesis of NAION is different than that of CRAO, resulting from ischemic damage to the optic nerve axons that leads to anterograde degeneration and death of the retinal ganglion cells. This damage is reflected histologically by loss of only the RNFL and ganglion cell layers and preservation of all other retinal layers. 16 Similarly, we found that in eyes with NAION, SD-OCT demonstrated thinning solely in the RNFL and ganglion cell layers.
Ghazi et al have previously reported on qualitative differentiating features between post-acute retinal arterial occlusion and non-acute optic neuropathies based on the typical characteristics of the macular OCT scans. 10 Our study supports these finding of qualitative differences but also includes quantitative differentiating features. We found a significantly greater thinning of the macula in eyes with CRAO compared to eyes with NAION. The mean difference in macular thickness between the eye with CRAO and the uninvolved eye (-59.7 ± 31.8 µm) was significantly larger than the same difference following NAION (-19.9 ± 8.4 µm). This difference was not matched in the amount of relative peripapillary RNFL thinning, which was similar in both conditions.
One of the major limitations of this study was the longer period from qualifying event to study inclusion in the group of patients with CRAO compared to those with NAION. However, because the mean duration from vision loss to NAION was 18 months, we think that this difference did not influence our results. Recently we have reported that in patients with NAION, RNFL thickness reaches a plateau at 6 months after acute vision loss and typically remains stable thereafter, with no further deterioration. 17 Others have reported similar results on the stability of RNFL thinning during the late atrophic stages of NAION. 18 In conclusion, distinguishing between CRAO and NAION during the acute or chronic phases usually poses no diagnostic challenge. However, this differentiation is not as easily made in some patients with long-standing visual loss who are only first examined when optic atrophy is already present. Fundus interpretation alone has previously been described as misleading, and in cases suspected of possible NAION versus CRAO, SD-OCT has been shown to be helpful in establishing the correct etiology. Despite causing a similar degree of RNFL loss, CRAO has been demonstrated to typically result in greater macular thinning compared to NAION.
